Allegro MicroSystems Announces Pricing of Primary Offering
Allegro MicroSystems Announces Pricing of Primary Offering
MANCHESTER, N.H., July 24, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. ("Allegro") (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the pricing of a primary offering of 25,000,000 shares of common stock at a public offering price of $24.00 per share, resulting in gross proceeds of $600,000,000 to Allegro (or $579,000,000 to Allegro after giving effect to the underwriters' discount of $0.84 per share). In addition, Allegro has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. Proceeds from the offering, together with cash on hand or additional borrowings under Allegro's term loan facility or revolving credit facility, will be used to repurchase shares from Allegro's majority shareholder, Sanken Electric Co., Ltd. ("Sanken") at a price per share equal to the price per share at which the underwriters will purchase shares of our common stock in the equity offering from Allegro. On an as adjusted basis after giving effect to the offering and the share repurchase, Sanken will hold approximately 33.2% (or 32.5% if the underwriters' option to purchase additional shares of Allegro's common stock is exercised in full) of Allegro's outstanding common stock. The offering is expected to close on or about July 26, 2024, subject to the satisfaction of customary closing conditions.
2024年7月24日,新罕布什爾州曼徹斯特(GLOBE NEWSWIRE) - Allegro Microsystems公司(以下簡稱“Allegro”)(納斯達克:ALGM)是動力和傳感解決方案的全球領導者運動控制和高效系統,今天宣佈股票的發行價格爲24.00美元,公開發行價,每股共25,000,000股,總收益爲6億美元。 Allegro的淨收益爲5.79億美元(考慮到承銷商折扣每股0.84美元)。此外,Allegro已經授予承銷商30天的選擇權,以購買額外的3,750,000股普通股,公開發行價,扣除承銷折扣和佣金。該發行所得收入,加上Allegro手頭的現金或Allegro的期限貸款或循環信用設施的額外借款,將用於以每股等於承銷商從Allegro購買普通股的價格回購來自Allegro的大部分股東Sanken Electric Co.,Ltd.(以下簡稱“Sanken”)。考慮到發行和股票回購後,Sanken將持有Allegro已發行普通股的約33.2%(若承銷商行使購買Allegro普通股的額外行權,Sanken持有的股份將爲32.5%)。該發行預計將於2024年7月26日前後結束,視情況而定。
Barclays, Morgan Stanley and UBS Investment Bank are acting as joint lead book-running managers for the offering. BofA Securities, Mizuho and Jefferies are acting as book-running managers for the offering. PJT Partners and Needham & Company are acting as co-managers for the offering. PJT Partners is also acting as financial advisor to Allegro.
巴克萊(Barclays)、摩根士丹利(Morgan Stanley)和瑞銀投資銀行(UBS Investment Bank)擔任本次發行的聯合主承銷商。美枝證券(BofA Securities)、瑞穗證券和傑富瑞證券(Jefferies)擔任本次發行的主承銷商。PJt Partners和Needham & Company擔任本次發行的聯席承銷商。PJt Partners還擔任Allegro的財務顧問。
This offering is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the "SEC") on July 23, 2024. The shares of common stock will be offered only by means of a prospectus supplement and the accompanying prospectus forming a part of the effective shelf registration statement. Before you invest, you should read the prospectus in that registration statement and the documents incorporated by reference in that registration statement, as well as the prospectus supplement related to this offering.
本次發行是根據2024年7月23日向美國證券交易委員會("SEC")提交的有效貨架註冊聲明進行的。普通股將僅通過發行的配售說明書和構成有效貨架註冊聲明的附帶的招股說明書提供出售。在您投資之前,應閱讀招股說明書及其所引用的在該註冊聲明中被納入的文件,以及與本次發行相關的配售說明書。
Copies of the final prospectus supplement related to this offering and the accompanying prospectus may be obtained, when available, from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone (toll-free): (888) 603-5847 or by emailing: barclaysprospectus@broadridge.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, New York, New York 10014, or by emailing: prospectus@morganstanley.com; or UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by telephone: (888) 827-7275 or by emailing: ol-prospectusrequest@ubs.com. You may also obtain these and the other documents referred to above for free by visiting the SEC's website at www.sec.gov.
本發行有關最終招股說明書及其附屬招股說明書的副本,如有需要,可從以下地點獲得:Barclays Capital Inc.,c/o Broadridge Financial Solutions,1155 Long Island Avenue,Edgewood,NY 11717,電話(免費電話):(888) 603-5847或通過電子郵件:barclaysprospectus@broadridge.com;摩根士丹利證券有限公司,Attention:Prospectus Department,180 Varick Street,New York,New York 10014,或通過電子郵件:prospectus@morganstanley.com;或UBS Securities LLC,Attention:Prospectus Department,1285 Avenue of the Americas,New York,NY 10019,電話:(888) 827-7275或通過電子郵件發送:ol-prospectusrequest@ubs.com。您也可以免費訪問美國證券交易委員會網站www.sec.gov了解上述文件。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Tonix Pharmaceuticals Holding Corp.*,是一家完全整合的生物製藥公司,致力於發展富有創新性的治療和預防潛在疾病的製劑。公司正在研發針對纖維肌痛患者的產品TNX-102 SL,已經完成了兩項具有統計學意義的3期研究。TNX-102 SL也正在被開發用於治療急性壓力反應以及類纖維肌痛的長期COVID。Tonix的神經系統藥物組合包括TNX-1300(可卡因酯酶),這是一種用於治療可卡因中毒、被授予“突破性療法”稱號的生物製品。Tonix的免疫學研發組合包括生物製品,用於治療器官移植排斥、自身免疫和癌症,包括TNX-1500,這是一種人源單克隆抗體,靶向CD40L(CD40L或CD154)用於預防異體移植器官排斥並用於治療自身免疫性疾病。Tonix在罕見疾病和傳染病領域的正在研發中的產品。商業子公司Tonix Medicines市場上銷售Zembrace SymTouch(舒馬曲坦注射液)3毫克和Tosymra(舒馬曲坦鼻噴劑)10毫克,用於成年急性偏頭疼的治療。
About Allegro MicroSystems
關於阿萊格羅微系統
Allegro MicroSystems, Inc. is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits ("ICs") and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro's diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power-saving technologies for data centers and clean energy applications.
Allegro MicroSystems,Inc.是一家領先的傳感器集成電路("ICs")和應用特定模擬功率ICs的全球設計師、開發商、無晶圓製造商和市場營銷商,可實現汽車和工業市場的新興技術。 Allegro的多樣化產品組合爲車輛電氣化,汽車ADAS安全功能,工業4.0自動化和節能技術以及數據中心和清潔能源應用提供高效可靠的解決方案。
About Sanken
關於匠電
Sanken's mission as a company is to provide optimal solutions in the broad and expansive field of electricity and electronics with semiconductors, its core business, power electronics and peripheral fields. Sanken provides products globally for the increasingly electrified automotive industry, as well as for white goods and industrial equipment, which are becoming more energy efficient as demand for electricity increases. Sanken Electric works to constantly innovate its technological capabilities and provides products of assured quality to help solve global environmental and social issues and further develop industry, the economy and culture.
Sanken作爲一家公司,其使命是爲半導體、電源電子和周邊領域在電力電子和小家電、工業設備及其他能源設備磁電化方面提供最佳方案。Sanken爲全球日益電氣化的汽車行業,以及因需求增加對電力需求更高效的白色家電和工業設備提供產品。Sanken Electric致力於不斷創新技術能力,並提供品質保證的產品,以幫助解決全球環境和社會問題,並進一步發展工業、經濟和文化。
Forward-Looking Statements
前瞻性聲明
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the sale of common stock in the offering, the closing of the offering and the repurchase of shares from Sanken, each as described above. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the factors discussed under the caption "Risk Factors" in the prospectus supplement related to this offering, our Annual Report on Form 10-K for the fiscal year ended March 29, 2024, filed with the SEC on May 23, 2024, and our other filings with the SEC, any of which could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
本新聞稿包含《1995年證券訴訟法》中規定的前瞻性聲明。本新聞稿中包含的所有與歷史事實無關的聲明均應視爲前瞻性聲明,包括有關本次發行普通股、發行結束、按上述說明從Sanken回購股份的聲明。這些前瞻性聲明基於管理層的當前預期。這些聲明既不構成承諾也不構成保證,但涉及已知和未知的風險、不確定性和其他重要因素,這些因素可能導致我們的實際結果、績效或成就與前瞻性聲明中表明的任何未來結果、績效或成就實質上有所不同。這些因素包括但不限於在與本次發行有關的招股說明書的“風險因素”標題下討論的事項,以及我們於2024年5月23日向美國證券交易委員會提交的2016年10K表格上的其他提交,及我們向美國證券交易委員會的其他提交,任何這些都可能導致實際結果與本新聞稿中所作的前瞻性聲明所示結果有實質性不同。這些前瞻性聲明代表管理層在發佈日的估計。雖然我們可能在將來某個時間選擇更新這些前瞻性聲明,但即使隨後發生的事件導致我們的觀點發生變化,我們也拒絕任何義務這樣做,除法律規定之外。這些前瞻性聲明不應作爲我們在本新聞稿發佈日以後的任何日期上的看法。
Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com
聯繫方式:
Jalene Hoover
投資者關係和企業通訊副總裁
+1 (512) 751-6526
jhoover@allegromicro.com